chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Weight
Clinical narrative: headache; tiredness/ fatigue; muscle aches; nausea; feeling like crap; BNT162B2 vaccine 1st dose 18Dec2020, 2nd dose 06Jan2021; fever; body ache; joint pain; chills; This is a spontaneous report from a contactable nurse, the patient. A 31-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 06Jan2021 (at the age of 31-years-old) as a single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 18Dec2020 (at the age of 31-years-old) for COVID-19 immunization. On 06Jan2021 at 21:00, the patient experienced headache, tiredness, muscle aches, nausea, "feeling like crap", but no injection site pain. On an unspecified date in Jan2021, the patient experienced fever for three days, body ache, joint pain, chills and fatigue and "everything". Treatment was not received for the events headache, tiredness, muscle aches, nausea, "feeling like crap", body ache, joint pain, chills and fatigue.  The clinical outcomes of headache, tiredness, muscle aches, nausea, "feeling like crap", body ache, joint pain, chills and fatigue were unknown; of fever was resolved on Jan2021 and of "BNT162B2 vaccine 1st dose 18Dec2020, 2nd dose 06Jan2021" was unknown.  Information about Lot/Batch Number has been requested.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Feeling hot, Flushing, Throat tightness, Vaccination site pain
Clinical narrative: her arm felt like it was on fire, body feels flushed, and felt like her throat was going to close up but it didn't; her arm felt like it was on fire, body feels flushed, and felt like her throat was going to close up but it didn't; her arm felt like it was on fire, body feels flushed, and felt like her throat was going to close up but it didn't; Injection site felt like it was on fire; Felt fine today and was fine 2-3 hours after the onset of the hot and fiery feeling; This is a spontaneous report from a contactable consumer. An 82-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E73246, expiry date not reported), via an unspecified route of administration on 06Jan2021 14:15 in the left arm at single dose for COVID-19 immunisation. Medical history included cardiac pacemaker insertion, high blood pressure for years. Concomitant medication included apixaban (ELIQUIS). The patient previously took flu shot (FLU VACCINE II) and never had a reaction to the flu shot, macrodantin and experienced drug hypersensitivity and hives. It was reported that about 15:15, injection site felt like it was on fire and then the whole arm felt like it was on fire. The patient got concerned. Her throat felt like it was going to close. Symptoms got less severe. She was fine yesterday and was fine that day. She called her doctor and was advised to put cold compresses on the arm and take Tylenol. She was ok. She read an article that stated if a person had a reaction to not have the second shot. She did not know if her reaction is severe. The second shot is due around 27Jan2021. She wanted to know what to do.  She felt fine on the day of report and was fine 2-3 hours after the onset of the hot and fiery feeling. It was scary and she didn't know what was happening. She also added that around 15:15, the injection arm felt like it was on fire. She felt flushed. Her throat felt like it would close up but never did. Everything resolved 2-3 hours after it started. Clinical outcome of the events was recovered on 06Jan2021.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; The initial case was missing the following minimum criteria: No adverse effect. Upon receipt of follow-up information on 10Jan2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer. A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced headache on an unspecified date. Therapeutic measures were taken as a result of headache that included Tylenol. Clinical outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: exposed to her 6 month old grand daughter who was positive; tested and received a positive test result, without symptoms.; tested and received a positive test result, without symptoms.; This is a spontaneous report from a contactable consumer.  A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration at the right arm on 30Dec2020 at a single dose for COVID-19 immunization.  Medical history included high blood pressure from 2001 and ongoing. There were no concomitant medications. Patient had the flu, shingles and pneumonia vaccines and a booster for MMR in the past 6 months. Patient was exposed to COVID-19 on 01Jan2021. Patient was tested on 07Jan2021 and received a positive test result on 08Jan2021. Patient does not have any symptoms. She was exposed to her 6 month old grand daughter who was positive. The doctor said he thinks it was a false positive. Outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Urticaria
Clinical narrative: Breaking out into a rash/ they look like little blotches or welts; breaking out into a rash/ they look like little blotches or welts; This is a spontaneous report from a contactable pharmacist, the patient. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Dec2020 as a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that a couple days after receiving the first dose of vaccination she started breaking out into a rash. It started off small on her wrist, then went away, then spread to her legs and went away, then to her neck and went away. The rash went all through her body, face and eyes. She still had the rash and was taking prednisone (MANUFACTURER UNKNOWN). The rash was all over, it looked like little blotches or welts. The patient asked if it was okay to get the second dose of vaccination after this reaction. The outcome was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Movement disorder, Pain in extremity, Peripheral swelling
Clinical narrative: severe leg and foot pain/severe arm pain; difficulty lifting arm; history of mild arthritis foot/Had Flare a week after first vaccine; Had flare a week after first vaccine with mild foot swelling; This is a spontaneous report from a contactable physician (patient). A 40-year-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Ej1685), via an unspecified route of administration on 17Dec2020 at 08:00 AM on Right arm at single dose for COVID-19 immunization in hospital. Medical history included possible asthma, left foot post traumatic arthritis with multiple surgeries including precious allograft, meralgia paresthetica left side otherwise healthy (History of mild arthritis foot and ankle surgery). Known allergies was none. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had history of mild arthritis foot and ankle surgery, she had flare a week after first vaccine with mild foot swelling but severe leg and foot pain in Dec2020, severe arm pain about 2 hours after vaccine with difficulty lifting arm for 24 hours after vaccine on 17Dec2020. Took mefenamic acid (ADVIL) for pain. Elevated feet for swelling. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as result of event 'severe leg and foot pain/severe arm pain' included mefenamic acid (ADVIL), for event 'foot swelling' included Elevated feet; no treatment was received for the other events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hypoaesthesia, Pain in extremity, Pyrexia
Clinical narrative: vomiting; rash on vaccine arm and vaccine thigh - not near the shot area; fever; chills; arm hurting; arm and fingers went numb for a few minutes; This is a spontaneous report from a contactable consumer. A 24-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration at site of left arm at 10:00 on 07Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient experienced arm and fingers went numb for a few minutes immediately after vaccine at 10:00 on 07Jan2021, fever, chills and arm hurting on 08Jan2021, vomiting, rash on vaccine arm and vaccine thigh - not near the shot area on 09Jan2021. Arm feeling better by end of 09Jan2021. Facility type vaccine was in Public Health Clinic facility. No other vaccine in four weeks. No other medications in two weeks. No treatment for adverse events. No COVID prior vaccination. No COVID tested post vaccination. None Known allergies. No other medical history. The outcome of events was recovering.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: vomiting; rash on vaccine arm and vaccine thigh - not near the shot area; fever; chills; arm hurting; arm and fingers went numb for a few minutes; This is a spontaneous report from a contactable consumer. A 24-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration at site of left arm at 10:00 on 07Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient experienced arm and fingers went numb for a few minutes immediately after vaccine at 10:00 on 07Jan2021, fever, chills and arm hurting on 08Jan2021, vomiting, rash on vaccine arm and vaccine thigh - not near the shot area on 09Jan2021. Arm feeling better by end of 09Jan2021. Facility type vaccine was in Public Health Clinic facility. No other vaccine in four weeks. No other medications in two weeks. No treatment for adverse events. No COVID prior vaccination. No COVID tested post vaccination. None Known allergies. No other medical history. The outcome of events was recovering.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Inappropriate schedule of product administration, Nausea
Clinical narrative: Fever 104 F.; Chilling; dizziness; nausea; first dose of  BNT162B2 on 21Dec2020, administration date 07Jan2021, dose number=2; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old patient of an unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number and expiry date unknown), intramuscular in left arm on 07Jan2021 at 15:30 at a single dose for COVID-19 immunisation.  The patient had no medical history and no known allergies.  There were no concomitant medications. Historical vaccine included first dose of  BNT162B2 on 21Dec2020 for COVID-19 immunisation. Patient did not receive any other vaccines prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. The patient experienced fever 104 F, chilling, dizziness and nausea on 08Jan2021 at 13:15. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering at the time of report.   Information on the lot/batch number has been requested.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 104 F.; Chilling; dizziness; nausea; first dose of  BNT162B2 on 21Dec2020, administration date 07Jan2021, dose number=2; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old patient of an unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number and expiry date unknown), intramuscular in left arm on 07Jan2021 at 15:30 at a single dose for COVID-19 immunisation.  The patient had no medical history and no known allergies.  There were no concomitant medications. Historical vaccine included first dose of  BNT162B2 on 21Dec2020 for COVID-19 immunisation. Patient did not receive any other vaccines prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. The patient experienced fever 104 F, chilling, dizziness and nausea on 08Jan2021 at 13:15. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering at the time of report.   Information on the lot/batch number has been requested.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Laboratory test
Clinical narrative: severe headaches; night sweats; severe bone crunching chills; light headedness/feeling faint; fever; muscle and joint ache/pain; muscle and joint ache/pain; nausea; This is a spontaneous report from a contactable nurse (patient). A 54-year-old female patient received the first dose of BNT162b2 (lot: EK 9231), via an unspecified route of administration in left arm on 26Dec2020 12:30 at single dose for covid-19 immunization. Medical history included subclinical hypothyroid, Premature ventricular contractions (PVC's), Migraines. Concomitant medication included metoprolol succinate (TOPROL), fesoterodine fumarate (TOVIAZ), levothyroxine, omeprazole, "multi v". The patient experienced severe headaches, night sweats, severe bone crunching chills, light headedness/feeling faint, fever, muscle and joint ache/pain, nausea on 28Dec2020 02:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received the urgent care, lab tests for these events. The patient's results of covid tests (Nasal Swab, covid swab) were Negative on 31Dec2020 and 05Jan2021. The patient was not pregnant at the time of vaccination. The outcome of the events was not recovered.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Night sweats, Pyrexia, SARS-CoV-2 test
Clinical narrative: severe headaches; night sweats; severe bone crunching chills; light headedness/feeling faint; fever; muscle and joint ache/pain; muscle and joint ache/pain; nausea; This is a spontaneous report from a contactable nurse (patient). A 54-year-old female patient received the first dose of BNT162b2 (lot: EK 9231), via an unspecified route of administration in left arm on 26Dec2020 12:30 at single dose for covid-19 immunization. Medical history included subclinical hypothyroid, Premature ventricular contractions (PVC's), Migraines. Concomitant medication included metoprolol succinate (TOPROL), fesoterodine fumarate (TOVIAZ), levothyroxine, omeprazole, "multi v". The patient experienced severe headaches, night sweats, severe bone crunching chills, light headedness/feeling faint, fever, muscle and joint ache/pain, nausea on 28Dec2020 02:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received the urgent care, lab tests for these events. The patient's results of covid tests (Nasal Swab, covid swab) were Negative on 31Dec2020 and 05Jan2021. The patient was not pregnant at the time of vaccination. The outcome of the events was not recovered.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: moderate supraclavicular lymph node sweeping and lymphadenopathy behind left ear and armpit on left side; This is spontaneous report from a contactable nurse (patient herself). A 44-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231; expiry date: unknown) intramuscular (left arm), on 06Jan2021 at 15:45, at a single dose, for COVID-19 immunization. The patient has no relevant medical history, no known allergies, and was not taking concomitant medications. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ek5730) intramuscular in the right arm on 16Dec2020 at 18:00, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in a workplace clinic. On 05Jan2021, at 16:30, the patient experienced moderate supraclavicular lymph node sweeping and lymphadenopathy behind left ear and armpit on left side. It was unknown if the patient received treatment for the events. Outcome of the events was not recovered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Fatigue, Pruritus, Rash, Swelling
Clinical narrative: itching of scalp, arms, legs; rash; abdominal hives; facial swelling; difficulty swallowing; swelling back of neck; inj site very sore; fatigue; This is a spontaneous report from a contactable nurse (patient). A 61-years-old female patient (no pregnant) started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK923) , via an unspecified route of administration on 29Dec2020 09:45 at the first single dose at arm left for covid-19 immunisation.  Medical history included known allergies: Sulfa.  The concomitant drug was unspecified. The patient previously took cipro and experienced drug hypersensitivity.  On 29Dec2020, the patient expected side effect of inj site very sore and fatigue for 24 hours. On 06Jan2021 14:00, the patient started with itching of scalp, arms, legs ,rash, and abdominal hives. Proceeded to facial swelling and difficulty swallowing, swelling back of neck, took 50 mg Benadryl w some relief. 630 PM symptoms reoccurred, took another 50 mg Benadryl with no relief. Symptoms intensified to severe swelling of the back of neck with intense pressure base of skull, radiating to top of head. Proceeded to the ER. The patient received Prednisone 50 mg orally and for the 4 days. The outcome of event inj site very sore and fatigue was recovered on 30Dec2020; the outcome of events was recovered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria, Vaccination site pain
Clinical narrative: itching of scalp, arms, legs; rash; abdominal hives; facial swelling; difficulty swallowing; swelling back of neck; inj site very sore; fatigue; This is a spontaneous report from a contactable nurse (patient). A 61-years-old female patient (no pregnant) started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK923) , via an unspecified route of administration on 29Dec2020 09:45 at the first single dose at arm left for covid-19 immunisation.  Medical history included known allergies: Sulfa.  The concomitant drug was unspecified. The patient previously took cipro and experienced drug hypersensitivity.  On 29Dec2020, the patient expected side effect of inj site very sore and fatigue for 24 hours. On 06Jan2021 14:00, the patient started with itching of scalp, arms, legs ,rash, and abdominal hives. Proceeded to facial swelling and difficulty swallowing, swelling back of neck, took 50 mg Benadryl w some relief. 630 PM symptoms reoccurred, took another 50 mg Benadryl with no relief. Symptoms intensified to severe swelling of the back of neck with intense pressure base of skull, radiating to top of head. Proceeded to the ER. The patient received Prednisone 50 mg orally and for the 4 days. The outcome of event inj site very sore and fatigue was recovered on 30Dec2020; the outcome of events was recovered.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Chills; Fever; Severe body aches; Lymphadenopathy; Exhaustion; This is a spontaneous report from a contactable physician (patient). A 44-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0140), via intramuscular route of administration on 06Jan2021 at a single dose on the left arm for COVID-19 immunization. Medical history included patient was diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other product. Concomitant medications included escitalopram oxalate (LEXAPRO), alprazolam, and estazolam. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07Jan2021 at 15:00, the patient experienced chills, fever, severe body aches, lymphadenopathy, and exhaustion. Treatment for the events included ibuprofen, Tylenol, sleep, and hot bath. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the events was recovering.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: felt muscle spasms almost every ten minutes  for three days in row; This is a spontaneous report from a contactable healthcare professional (patient herself). A 38-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiry date not reported), via an unspecified route of administration in the left arm on 19Dec2020 07:45 at single dose for COVID-19 immunisation. Medical history included Bell's palsy from Jun2020 to an unknown date, and low Vitamin D.  The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included zinc (ZINC), ergocalciferol (VIT D), vitamin c, vitamin b6, and cyanocobalamin (VITAMIN B12). One week and a half after she received her COVID vaccine, on 30Dec2020 at 10:00, the patient felt muscle spasms almost every ten minutes for three days in row. No treatment was received for the adverse events. Clinical outcome of the event was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Product use issue
Clinical narrative: Mild Headache following second dose; patient was administered the second dose of another vaccine (unspecified, lot no: EK4176) on the left deltoid on the same day, 08Jan2021, as the COVID-19 vaccine; This is a spontaneous report from a contactable physician (patient).  A 72-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot no: EL4176), via an unspecified route of administration on 08Jan2021 at 18:30 on the left arm at a single dose for COVID-19 immunization. The patient had no medical history and no known allergies. The patient received other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was administered the second dose of another vaccine (unspecified, lot no: EK4176) on the left deltoid on the same day, 08Jan2021, as the COVID-19 vaccine. The patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot no: EK5730) on 19Dec2020 at 6:30 AM on the left arm at a single dose for COVID-19 immunization. The patient has not been diagnosed with COVID-19 prior to the vaccination. The patient received the vaccine in the hospital. It was reported that the patient received another vaccine (unspecified, lot no: EK4176) on the same day of the second dose, 08Jan2021. It was reported that the patient experienced a mild headache following second dose on 09Jan2021 at 06:00.  The patient did not receive any treatment for the adverse event. The patient was recovering from the event. The event was reported as non-serious. The patient has not been tested for COVID-19 since the vaccination.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Body temperature, Chills
Clinical narrative: Beginning the day I got the 2nd shot, I had arm pain./severe arm pain/hand in the arm I got the shot; chills; fever (100.7° F); nausea; muscle aches; loss of appetite; joint pain/elbow, wrist; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; This is a spontaneous report from a contactable other Health Professional (patient). A 22-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on 07Jan2021 09:45 at single dose in left arm for covid-19 immunization. Medical history included OCD (obsessive-compulsive disorder)/anxiety, obesity. The patient had no allergies to medications, food, or other products. Concomitant medications the patient received within 2 weeks of vaccination included fluvoxamine and ethinylestradiol, norgestimate (SPRINTEC). The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07Jan2021 22:45, beginning the day the patient got the 2nd shot, the patient had arm pain. That night (on 07Jan2021 22:45), she had chills, fever (100.7 F), nausea, muscle aches, loss of appetite, joint pain, and severe arm pain that radiated to her armpit, back, elbow, wrist, and hand in the arm she got the shot. This all lasted about 24 hours. The arm pan has been present for about 2 days now. No treatment was received. The outcome of the event arm pain was recovered on 09Jan2021; the outcome of the rest events was recovered on 08Jan2021.  information on the lot/batch number has been requested.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Beginning the day I got the 2nd shot, I had arm pain./severe arm pain/hand in the arm I got the shot; chills; fever (100.7° F); nausea; muscle aches; loss of appetite; joint pain/elbow, wrist; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; This is a spontaneous report from a contactable other Health Professional (patient). A 22-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on 07Jan2021 09:45 at single dose in left arm for covid-19 immunization. Medical history included OCD (obsessive-compulsive disorder)/anxiety, obesity. The patient had no allergies to medications, food, or other products. Concomitant medications the patient received within 2 weeks of vaccination included fluvoxamine and ethinylestradiol, norgestimate (SPRINTEC). The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07Jan2021 22:45, beginning the day the patient got the 2nd shot, the patient had arm pain. That night (on 07Jan2021 22:45), she had chills, fever (100.7 F), nausea, muscle aches, loss of appetite, joint pain, and severe arm pain that radiated to her armpit, back, elbow, wrist, and hand in the arm she got the shot. This all lasted about 24 hours. The arm pan has been present for about 2 days now. No treatment was received. The outcome of the event arm pain was recovered on 09Jan2021; the outcome of the rest events was recovered on 08Jan2021.  information on the lot/batch number has been requested.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Malaise, Vaccination site pain
Clinical narrative: General malaise about three days after vaccination; moderate soreness at left deltoid running down thru left shoulder and mid back.; moderate soreness at left deltoid running down thru left shoulder and mid back.; moderate soreness at left deltoid running down thru left shoulder and mid back.; experienced headaches off and on for about three days; This is a spontaneous report from a contactable pharmacist reporting for himself.  A 51-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot EJ1685, intramuscularly on 21Dec2020 (Dose 1) as a single dose, left arm  (age at vaccination: 51 years)  for COVID-19 immunization.  Medical history was none. There were no known allergies to medications, food, or other products. He was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included multivitamins, krill oil (KRILL OIL).  No other vaccines were received in the 4 weeks prior to COVID vaccination. Starting 21Dec2020 at 18:00 after the first vaccine, the patient experienced headaches off and on for about three days, usually at night especially while trying to sleep. General malaise about three days after vaccination (on 24Dec2020) which lasted about four days. Also had moderate soreness at left deltoid running down thru left shoulder and mid back (onset 21Dec2020 18:00). There was no treatment received or hospitalization for the events. The events were reported as non-serious. The outcome of the event headaches off and on was recovered in Dec2020, for the event general malaise was recovered on 28Dec2020 and for the event moderate soreness at left deltoid running down thru left shoulder and mid back was recovered on an unknown date. The patient was not COVID-tested post-vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018615 same patient/drug, different dose/event
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vaccination site pain
Clinical narrative: Extremely tired, sore at the injection site, a headache, chills; Extremely tired, sore at the injection site, a headache, chills; Extremely tired, sore at the injection site, a headache, chills; Extremely tired, sore at the injection site, a headache, chills; This is a spontaneous report from a contactable healthcare professional.  A 57-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# EK9381, intramuscularly on 08Jan2021 07:30 as a single dose, right arm (age at vaccination: 57 years old) for COVID-19 immunization. Medical history included breast cancer survivor and diagnosed with COVID-19.  The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included gabapentine (GABAPENTINE).  On 08Jan2021 17:00, the patient experienced being extremely tired, sore at the injection site, a headache, and chills. Therapeutic measures were taken as a result of the events and included "Tylenol sleep." The events did not require hospitalization and were reported as non-serious. The clinical outcome of the events extremely tired, sore at the injection site, a headache, and chills was not recovered. The patient was not COVID tested post-vaccination.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm on day of vaccination (dose 1); This is a spontaneous report from a Non-contactable consumer (patient). A 63-Year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient experienced sore arm on day of vaccination (dose 1) on 08Jan2021. The event happened on Friday, 08Jan the patient became aware on the evening of Friday, 08Jan. He reported the event on Saturday, 09Jan using the information he had received on the 8th (He did not receive further information on the 9th). The most recent COVID-19 vaccine was administered at Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No Covid prior vaccination. No Covid tested post vaccination. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Decreased appetite, Headache, Peripheral swelling, Petechiae
Clinical narrative: Sleepiness; pain at site for >24hrs less than 48hrs; itching on arm below injection site; headache; petichiae on site arm below injection site; sneezing; vivid dreams; swelling in legs; lower appetite; thirsty; more frequently urination with larger amounts; more frequently urination with larger amounts; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 04Jan2021 at 15:45 on arm at single dose for COVID-19 immunization. Medical history included Chronic sinusitis and had known allergies with Gluten and Sulfa. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tizanidine hydrochloride (TANIN, reported as tanins) and had known allergy. The patient experienced sleepiness, pain at site for more than 24hours less than 48hours, itching on arm below injection site, headache, petichiae on site arm below injection site, sneezing, vivid dreams, swelling in legs, lower appetite, thirsty, more frequently urination with larger amounts on 04Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria, Pruritus, Sneezing, Somnolence, Thirst
Clinical narrative: Sleepiness; pain at site for >24hrs less than 48hrs; itching on arm below injection site; headache; petichiae on site arm below injection site; sneezing; vivid dreams; swelling in legs; lower appetite; thirsty; more frequently urination with larger amounts; more frequently urination with larger amounts; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 04Jan2021 at 15:45 on arm at single dose for COVID-19 immunization. Medical history included Chronic sinusitis and had known allergies with Gluten and Sulfa. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tizanidine hydrochloride (TANIN, reported as tanins) and had known allergy. The patient experienced sleepiness, pain at site for more than 24hours less than 48hours, itching on arm below injection site, headache, petichiae on site arm below injection site, sneezing, vivid dreams, swelling in legs, lower appetite, thirsty, more frequently urination with larger amounts on 04Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Urine output increased, Vaccination site pain
Clinical narrative: Sleepiness; pain at site for >24hrs less than 48hrs; itching on arm below injection site; headache; petichiae on site arm below injection site; sneezing; vivid dreams; swelling in legs; lower appetite; thirsty; more frequently urination with larger amounts; more frequently urination with larger amounts; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 04Jan2021 at 15:45 on arm at single dose for COVID-19 immunization. Medical history included Chronic sinusitis and had known allergies with Gluten and Sulfa. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tizanidine hydrochloride (TANIN, reported as tanins) and had known allergy. The patient experienced sleepiness, pain at site for more than 24hours less than 48hours, itching on arm below injection site, headache, petichiae on site arm below injection site, sneezing, vivid dreams, swelling in legs, lower appetite, thirsty, more frequently urination with larger amounts on 04Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for the Covid virus; Tested positive for the Covid virus; This is a spontaneous report from a contactable nurse.  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient received the first dose of the vaccine on 29Dec2020 and four days ago, he tested positive for the Covid virus (02Jan2021). The outcome of the event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Test positive for the Covid virus found 4 day following the vaccination, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Headache, Nausea
Clinical narrative: 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0/22 hours in - temp of 101.3, chills, body aches; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0/22 hours in - temp of 101.3, chills, body aches; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0; 16 hours in - temp of 100.6, loose stools (mushy to watery)/18 hours in - temp of 101.2/22 hours in - temp of 101.3, chills, body aches; 16 hours in - temp of 100.6, loose stools (mushy to watery); Immediate - headache/23 hours in - headache, temp of 99.9; 8 hours in - soreness in arm/upper body; 8 hours in - soreness in arm/upper body; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number El3249), intramuscularly on right arm at 12:30 on 08Jan2021 at single dose for COVID-19 immunization. Medical history included anxiety, depression and migraine. Concomitant medication included escitalopram oxalate (LEXAPRO), docusate;senna, melatonin, ibuprofen, no other vaccine in four weeks. The patient received her first dose of BNT162B2 (Lot number EJ1685) intramuscularly on right arm at 03:00 PM on 18Dec2020 for COVID-19 immunization. After vaccination on 08Jan2021, the patient experienced immediate headache, 8 hours in: soreness in arm/upper body; 15 hours in (on 09Jan2021): woke up with chills, body aches, nausea/vomiting, temp of 99.0; 16 hours in: temp of 100.6, loose stools (mushy to watery); 18 hours in: temp of 101.2; 22 hours in: temp of 101.3, chills, body aches finally able to take Tylenol 1000mg; 23 hours in: headache, temp of 99.9. The outcome of events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0/22 hours in - temp of 101.3, chills, body aches; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0/22 hours in - temp of 101.3, chills, body aches; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0; 15 hours in - woke up with chills, body aches, nausea/vomiting, temp of 99.0; 16 hours in - temp of 100.6, loose stools (mushy to watery)/18 hours in - temp of 101.2/22 hours in - temp of 101.3, chills, body aches; 16 hours in - temp of 100.6, loose stools (mushy to watery); Immediate - headache/23 hours in - headache, temp of 99.9; 8 hours in - soreness in arm/upper body; 8 hours in - soreness in arm/upper body; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number El3249), intramuscularly on right arm at 12:30 on 08Jan2021 at single dose for COVID-19 immunization. Medical history included anxiety, depression and migraine. Concomitant medication included escitalopram oxalate (LEXAPRO), docusate;senna, melatonin, ibuprofen, no other vaccine in four weeks. The patient received her first dose of BNT162B2 (Lot number EJ1685) intramuscularly on right arm at 03:00 PM on 18Dec2020 for COVID-19 immunization. After vaccination on 08Jan2021, the patient experienced immediate headache, 8 hours in: soreness in arm/upper body; 15 hours in (on 09Jan2021): woke up with chills, body aches, nausea/vomiting, temp of 99.0; 16 hours in: temp of 100.6, loose stools (mushy to watery); 18 hours in: temp of 101.2; 22 hours in: temp of 101.3, chills, body aches finally able to take Tylenol 1000mg; 23 hours in: headache, temp of 99.9. The outcome of events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Body temperature, Headache, Myalgia
Clinical narrative: Low-grade fever; severe joint/muscle aches; severe joint/muscle aches; headache; loss of taste; This is a spontaneous report from a contactable nurse (patient). A 53-year-old non-pregnant female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 18Dec2020 at single dose in right arm for covid-19 immunization. Medical history included hypertension and anxiety. No other vaccine was received in for weeks. Concomitant medications in two weeks included losartan, famotidine, aspirin (acetylsalicylic acid), prazosin, escitalopram. The patient did not have COVID prior vaccination and patient did not underwent COVID tested post vaccination. The patient experienced low-grade fever, severe joint/muscle aches, headache, loss of taste on 19Dec2020 01:00. The patient did not receive any treatments of the events. The outcome of the events was recovered on an unspecified date.  Information on Lot/Batch has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Low-grade fever; severe joint/muscle aches; severe joint/muscle aches; headache; loss of taste; This is a spontaneous report from a contactable nurse (patient). A 53-year-old non-pregnant female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 18Dec2020 at single dose in right arm for covid-19 immunization. Medical history included hypertension and anxiety. No other vaccine was received in for weeks. Concomitant medications in two weeks included losartan, famotidine, aspirin (acetylsalicylic acid), prazosin, escitalopram. The patient did not have COVID prior vaccination and patient did not underwent COVID tested post vaccination. The patient experienced low-grade fever, severe joint/muscle aches, headache, loss of taste on 19Dec2020 01:00. The patient did not receive any treatments of the events. The outcome of the events was recovered on an unspecified date.  Information on Lot/Batch has been requested.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine, Blood pressure increased, Blood pressure measurement, Flank pain, Metabolic function test
Clinical narrative: 3h after receiving the first shot, I developed symmetric flank pain in the mid-thoracic area that persisted about 28 hours.  No CVA tenderness; elevated BP of 132/85; This is a spontaneous report from a contactable physician (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on his left arm on 07Jan2021 18:00 at a single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medications included acetylsalicylic acid (ASPIRIN [ACETYLSALICYLIC ACID]) and naproxen. Three hours after receiving the first shot (07Jan2021 at 22:00), patient developed symmetric flank pain in the mid-thoracic area that persisted about 28 hours. No CVA tenderness. The following morning, he had an elevated BP of 132/85 that persisted this morning (120/98). His normal BP is 110/70. Checked a creatinine and metabolic panel on 07Jan2021, all normal. There was no treatment received for the adverse events. The outcome of the events was recovering.